🏆 Deal of the Week · CW 33/2023
Royal Philips raised EUR 2.6 billion in a Private Equity transaction in August 2023, with valuation terms remaining undisclosed. The deal was led by EXOR N.V., which acquired a 15% stake in Philips through the transaction. The investment marks one of the largest single-investor commitments to a European health technology company in 2023.
ExorPhilips — key deal facts
| Company | ExorPhilips |
| Founded | 1891 |
| Headquarters | Amsterdam, Netherlands |
| Amount raised | EUR 2,6 B |
| Valuation | Valuation Remains Undisclosed |
| Round | Private Equity |
| Investors | EXOR N.V. (https://www.exor.com/) |
| Sectors | Health Care |
Who invested in ExorPhilips?
EXOR N.V., the Amsterdam-based diversified holding company led by CEO John Elkann, was the sole investor in this transaction. EXOR's involvement is strategically notable given its established track record of long-term anchor stakes in major European industrial and consumer companies, including Ferrari and Stellantis. The commitment signals EXOR's deliberate expansion into health technology as a core portfolio vertical.
What does ExorPhilips do?
Royal Philips is a global health technology company headquartered in Amsterdam, Netherlands, founded in 1891 by Gerard and Anton Philips. The company develops and manufactures diagnostic imaging systems, ultrasound equipment, image-guided therapy platforms, patient monitoring solutions, and enterprise health informatics software. Under CEO Roy Jakobs, Philips has been executing a strategic transformation to focus exclusively on healthcare, exiting its former consumer electronics businesses. Philips serves hospitals, clinics, and healthcare professionals across more than 100 countries.
ExorPhilips valuation & multiples
No verified EV/Sales or EV/EBITDA multiples data was supplied for this transaction. Once comparable multiples become available, they will be benchmarked against prevailing Health Care sector valuation ranges. Readers seeking current sector reference multiples are encouraged to visit the Venionaire DealMatrix Health Care sector multiples pages.
Frequently asked questions
How much did ExorPhilips raise in its Private Equity round?
Royal Philips raised EUR 2.6 billion in a Private Equity transaction in August 2023.
What is ExorPhilips's valuation?
The valuation associated with this transaction remains undisclosed.
Who invested in ExorPhilips?
EXOR N.V. was the sole investor, acquiring a 15% stake in Royal Philips.
When was ExorPhilips founded and where is it based?
Royal Philips was founded in 1891 and is headquartered in Amsterdam, Netherlands.
Source: original announcement — read the full report.